G23.3 Hypomyelination with atrophy of the basal ganglia and cerebellum

✓ Billable ICD-10-CM 2026
Open G23.3 in Web App →

The ICD-10-CM code for Hypomyelination with atrophy of the basal ganglia and cerebellum is G23.3 (FY2026). It is a billable, claim-ready diagnosis code.

Classification

Section
G20-G26: Extrapyramidal and movement disorders (G20-G26)
Category G23
7 codes (6 billable)
FY2026 Status
Stable since FY2024

Also Known As

ICD-10-CM Alphabetic Index entries that lead to G23.3:

  • Hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC)
  • H-ABC (hypomyelination with atrophy of the basal ganglia and cerebellum)
  • Disorder (of) › neurological NEC › TUBB4A-related

Inclusion Terms

  • H-ABC
  • TUBB4A-related neurologic disorders

U.S. Hospital Utilization

G23.3 appeared in too few sampled U.S. inpatient stays in 2023 to report a national estimate (AHRQ suppresses counts of 10 or fewer) — a rare inpatient diagnosis.

Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.

Official Coding Guidelines

Dominant/nondominant side (TOC entry)

a. Dominant/nondominant side ................................................................................................. 45

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.6.a
Pain - Category G89 (TOC entry)

b. Pain - Category G89.............................................................................................................. 45

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.6.b

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

Related Codes

Search all 70,000+ ICD-10-CM codes →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2025-10-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial